Clinical Research Fellow, Oxford Centre for Clinical Magnetic Resonance Research, Oxford University, UK
Dr. Hundertmark is a fully licensed doctor in both the UK and Germany.
He is currently a Senior Research Fellow at Oxford University where he is completing the final year of his DPhil (PhD), investigating new pharmaceutical targets for heart failure patients in clinical trials.
He sees NHS patients at the John Radcliffe Hospital, Oxford. Until August 2021 he also held a role in Cardiology and Cardio-Thoracic surgery at The Harley Street Clinic, London (HCA Healthcare UK) where he regularly saw oncology patients for interventional management, such as radiofrequency ablation of cancerous tissues, and pleurodesis for recurrent cancer related pleural effusions.
His research interest lies in the field of energy metabolism and how both pharmacological and lifestyle interventions may augment failing organ systems. He has recently concentrated on novel spectroscopy imaging techniques to further investigate patients with cardio-metabolic diseases and has published on these topics in high-impact journals, such as the European Heart Journal and Circulation.
During the early part of his career, he gained extensive international experience, completing his undergraduate degree, and qualifying as a doctor in Würzburg (Germany), Bern (Switzerland) and Johannesburg (South Africa). He then began to train in general internal medicine and cardiology at University Hospital, Würzburg, and his MD thesis investigated a mutation in a gene causing dilated cardiomyopathy. This was followed by a role in intensive care medicine at the University Clinic Halle (Germany) before relocation to UK to pursue an academic career in Oxford.
He now actively represents aspiring internal medicine physicians as the Chair of the working group for Europe’s biggest medico-scientific society (German Society for Internal Medicine, DGIM).
Dr Hundertmark’s strong clinical background and European experience, combined with a research focus on metabolic systems and pathways, makes him an excellent fit with the medical team at COC.